fda reconsiders tirzepatide says compounding pharmacies can keep making weight-loss med tirzepatide, for now FDA to reconsider removal of

2123 The Effect of GLP-1RAs on Systemic Inflammation The ability of GLP-1RAs to reduce systemic inflammation (with decreases in hs-C-reactive protein, TNF-, interleukin-6 and interleukin IL-1) has been demonstrated in animal studies, studies on isolated human tissues and RCTs

Immunity Boost IV A powerful mix of Vitamin C, zinc, and antioxidants to support immune health and speed recovery from illness or travel fatigue

Take the first step towards a healthier, happier you and find out if youre eligible today

Wegovy (semaglutide) should be injected once a week on the same day each week

The FDA approved it as Foundayo on April 1, 2026, for weight management in adults with obesity or overweight with weight-related conditions

This dual-action mechanism regulates appetite signaling in the brain, slows stomach emptying, and improves insulin sensitivitythree mechanisms that work together to produce sustained weight reduction